Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, UVA Health diabetes experts note in a new paper highlighting a growing ...

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

A new study by UVA Health experts reveals that nearly 40% of type 2 diabetes patients stop their medication within a year.

The following is a summary of “Development of a patient decision aid for type 2 diabetes mellitus: a patient-centered ...

the company has introduced anti-counterfeit security bands and multilingual patient education materials. "As we expand our chronic portfolio, launching empagliflozin aligns with our mission to improve ...